- Home
- HUT vs AXSM Comparison
HUT vs AXSM Comparison
Compare HUT & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HUT | AXSM |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 12.0B |
| IPO Year | 2023 | 2015 |
Fundamental Metrics
Financial Performance| Metric | HUT | AXSM |
|---|---|---|
| Price | $92.04 | $229.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 17 |
| Target Price | $65.20 | ★ $211.12 |
| AVG Volume (30 Days) | ★ 3.8M | 878.2K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $235,118,000.00 | N/A |
| Revenue This Year | $161.69 | $57.24 |
| Revenue Next Year | N/A | $55.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 44.79 | N/A |
| 52 Week Low | $18.68 | $96.09 |
| 52 Week High | $140.80 | $260.19 |
Technical Indicators
Market Signals| Indicator | HUT | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 38.47 | 42.60 |
| Support Level | $89.69 | $217.15 |
| Resistance Level | $112.33 | $236.26 |
| Average True Range (ATR) | 10.02 | 9.67 |
| MACD | -2.04 | -2.07 |
| Stochastic Oscillator | 20.04 | 18.57 |
Price Performance
Historical ComparisonAbout HUT Hut 8 Corp.
Hut 8 Corp is an energy infrastructure platform that integrates power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.